Abstract:Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas-associated systems have recently emerged as a focal point for developing next-generation molecular diagnosis, particularly for nucleic acid detection. However, the detection of proteins is equally critical across diverse applications in biology, medicine, and the food industry, especially for diagnosing and prognosing diseases like cancer, Alzheimer and cardiovascular conditions. Despite recent efforts to adapt CRISPR/Cas systems for protein detection with immunoassays, these methods typically achieved sensitivity only in the femtomolar to picomolar range, underscoring the need for enhanced detection capabilities. To address this, we developed CRISPR-AMPED, an innovative CRISPR/Cas-based immunoassay enhanced by magnetic proximity extension and detection. This approach combines proximity extension assay (PEA) with magnetic beads that converts protein into DNA barcodes for quantification with effective washing steps to minimize non-specific binding and hybridization, therefore reducing background noise and increasing detection sensitivity. The resulting DNA barcodes are then detected through isothermal nucleic acid amplification testing (NAAT) using recombinase polymerase amplification (RPA) coupled with the CRISPR/Cas12a system, replacing the traditional PCR. This integration eliminates the need for thermocycling and bulky equipment, reduces amplification time, and provides simultaneous target and signal amplification, thereby significantly boosting detection sensitivity. CRISPR-AMPED achieves attomolar level sensitivity, surpassing ELISA by over three orders of magnitude and outperforming existing CRISPR/Cas-based detection systems. Additionally, our smartphone-based detection device demonstrates potential for point-of-care applications, and the digital format extends dynamic range and enhances quantitation precision. We believe CRISPR-AMPED represents a significant advancement in the field of protein detection.

A Target-Driven DNA-based Molecular Machine for Rapid and Homogeneous Detection of Arginine-Vasopressin.

Ultrasensitive Detection of Aminopeptidase N Activity in Urine and Cells with a Ratiometric Fluorescence Probe

Colorimetric Detection of Proteins Based on Target-Induced Activation of Aptazyme.

Programmable DNA Nanomachine Integrated with Electrochemically Controlled Atom Transfer Radical Polymerization for Antibody Detection at Picomolar Level

A cAMP-biosensor-based assay for measuring plasma arginine–vasopressin levels

Target-induced DNA nanomachine operation for the detection of proteins

Sensitive detection of dipeptidyl peptidase based on DNA-peptide conjugates and double signal amplification of CHA and DNAzymes

Rapid Determination of Dopamine in Human Plasma Using a Gold Nanoparticle-Based Dual-Mode Sensing System

Intelligent DNA Machine for the Ultrasensitive Colorimetric Detection of Nucleic Acids.

A Fluorescent Biosensing Platform Based on the Polydopamine Nanospheres Intergrating with Exonuclease III-assisted Target Recycling Amplification.

Probing Cellular Molecules with PolyA-Based Engineered Aptamer Nanobeacon

Ultrasensitive reporter DNA sensors built on nucleic acid amplification techniques: Application in the detection of trace amount of protein

Aligner-mediated Cleavage-Triggered Exponential Amplification for Sensitive Detection of Nucleic Acids.

A DNA machine for sensitive and homogeneous DNA detection via lambda exonuclease assisted amplification.

Enhanced CRISPR/Cas-Based Immunoassay through Magnetic Proximity Extension and Detection

SARS-CoV-2 monitoring by automated target-driven molecular machine-based engineering

A Highly Selective Implantable Electrochemical Fiber Sensor for Real-Time Monitoring of Blood Homovanillic Acid.

A Programmable DNAzyme for the Sensitive Detection of Nucleic Acids

Single-Molecule Sensing of Acidic Catecholamine Metabolites Using a Programmable Nanopore

Peptide–nucleic acid aptamer pair biosensor for disease biomarker detection in clinical samples

Label-free electrochemical monitoring of vasopressin in aptamer-based microfluidic biosensors